Showing results (161-170 of 969) with videos related to

Sort By:
Pageof 97
Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.
American Journal of Hematology|May 29, 2015
Bone marrow necrosis in acute leukemia: Clinical characteristic and outcomeTalha Badar, Aditya Shetty, Carlos Bueso-Ramos, et al.
Blood Advances|January 21, 2022
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVADNaveen Pemmaraju, Nathaniel R Wilson, Guillermo Garcia-Manero, et al.
Cancer|March 18, 2025
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemiaAlexandre Bazinet, Alex Bataller, Tapan Kadia, et al.
American Journal of Hematology|November 5, 2014
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemiaTapan M Kadia, Hagop M Kantarjian, Deborah A Thomas, et al.
Blood Cancer Discovery|January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?Spencer C Wei, James J Mancuso, Naval Daver, et al.
Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.
Blood Neoplasia|June 2, 2025
Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMMLSamuel Urrutia, Prithviraj Bose, Yesid Alvarado, et al.
Frontiers in Oncology|May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We StandAlessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Leukemia & Lymphoma|October 4, 2017
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage settingPrajwal Boddu, Abdul Rashid Shah, Gautam Borthakur, et al.
Pageof 97